These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3138098)

  • 41. Economic benefits of improved insulin stability in insulin pumps.
    Weiss RC; van Amerongen D; Bazalo G; Aagren M; Bouchard JR
    Manag Care; 2011 May; 20(5):42-7. PubMed ID: 21667627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetic ketoacidosis due to insulin resistance treated by haemodialysis.
    Sheldon J; Hollis PR; Trafford JA; Cook JG
    Diabet Med; 1985 Jan; 2(1):59-60. PubMed ID: 2951069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restoration and maintenance of intravenous insulin infusion in the vapor-pressure powered implantable infusion device.
    Kernstine KH; Kryjeski SR; Ekerholm PA; Wigness BD; Rohde TD; Dorman FD; Buchwald H
    ASAIO Trans; 1988; 34(3):371-4. PubMed ID: 3196535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Ketoacidosis without hyperglycemia in a diabetic patient treated with the portable insulin infusion pump].
    Vialettes B; Lassmann V; Pfister B; Vague P
    Presse Med; 1985 Jul; 14(27):1474. PubMed ID: 3161066
    [No Abstract]   [Full Text] [Related]  

  • 45. Predicting risk of diabetic ketoacidosis in patients using continuous subcutaneous insulin infusion.
    Bradley C; Gamsu DS; Knight G; Boulton AJ; Ward JD
    Br Med J (Clin Res Ed); 1986 Jul; 293(6541):242-3. PubMed ID: 3089472
    [No Abstract]   [Full Text] [Related]  

  • 46. Glycerol prevents insulin precipitation and interruption of flow in an implantable insulin infusion pump.
    Blackshear PJ; Rohde TD; Palmer JL; Wigness BD; Rupp WM; Buchwald H
    Diabetes Care; 1983; 6(4):387-92. PubMed ID: 6311499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modeling absorption kinetics of subcutaneous injected soluble insulin.
    Mosekilde E; Jensen KS; Binder C; Pramming S; Thorsteinsson B
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):67-87. PubMed ID: 2654357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Insulin preparation for clinical use].
    Kanazawa Y
    Nihon Rinsho; 1990 Dec; 48 Suppl():977-81. PubMed ID: 2086979
    [No Abstract]   [Full Text] [Related]  

  • 49. The insulin pump as murder weapon: a case report.
    Benedict B; Keyes R; Sauls FC
    Am J Forensic Med Pathol; 2004 Jun; 25(2):159-60. PubMed ID: 15166770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Trial of an insulin solution, concentrated to 100 u/ml, in peritoneal infusion using a portable pump].
    Selam JL; Zirinis P; Mirouze J; Cavailhe G; Chanlat P
    Presse Med; 1984 May; 13(21):1339. PubMed ID: 6233566
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-Term Constant Subcutaneous Drug Administration.
    Liu S; Miyoshi M
    Methods Mol Biol; 2018; 1868():17-22. PubMed ID: 30244450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterizing normal-use temperature conditions of pumped insulin.
    Herr JK; Keith S; Klug R; Pettis RJ
    J Diabetes Sci Technol; 2014 Jul; 8(4):850-4. PubMed ID: 24876429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin compatibility with polymer materials used in external pump infusion systems.
    Melberg SG; Havelund S; Villumsen J; Brange J
    Diabet Med; 1988 Apr; 5(3):243-7. PubMed ID: 2967145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Suppression of the wound dressing at the exit of the catheter in diabetic patients treated with an intraperitoneal portable insulin pump].
    Saeidi S; Selam JL; Mirouze J
    Presse Med; 1986 Sep; 15(28):1330. PubMed ID: 2950397
    [No Abstract]   [Full Text] [Related]  

  • 55. Insulin Infusion Sets: A Critical Reappraisal.
    Heinemann L
    Diabetes Technol Ther; 2016 May; 18(5):327-33. PubMed ID: 26885764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deaths among patients using continuous subcutaneous insulin infusion pumps - United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Feb; 31(7):80-2, 87. PubMed ID: 6801463
    [No Abstract]   [Full Text] [Related]  

  • 57. Insulin pump in New Zealand.
    Bryson L
    Diabetes Educ; 1983; 8(4):39-40. PubMed ID: 6337796
    [No Abstract]   [Full Text] [Related]  

  • 58. Assessment of gelling in insulin solutions for infusion pumps.
    Hutchison KG
    J Pharm Pharmacol; 1985 Aug; 37(8):528-31. PubMed ID: 2864410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interference at work: a case report of a malfunctioning insulin pump.
    Reiher AE; Gallagher TA; Emanuele MA
    Endocrine; 2009 Feb; 35(1):22-4. PubMed ID: 19082930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin pump delivery during parenteral hyperalimentation.
    Wieland RG; Barnett M; Williams P; Cummins P
    Diabetes Care; 1986; 9(1):97-8. PubMed ID: 3081309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.